1. Comprehensive Nonclinical Safety Assessment of Nirmatrelvir Supporting Timely Development of the SARS-COV-2 Antiviral Therapeutic, Paxlovid™. (August 2022) Authors: Sathish, Jean G.; Bhatt, Siddhartha; DaSilva, Jamie K.; Flynn, Declan; Jenkinson, Stephen; Kalgutkar, Amit S.; Liu, Maggie; Manickam, Balasubramanian; Pinkstaff, Jason; Reagan, William J.; Shirai, Norimitsu; Shoieb, Ahmed M.; Sirivelu, Madhu; Vispute, Saurabh; Vitsky, Allison; Walters, Karen; Wis... Journal: International journal of toxicology Issue: Volume 41:Number 4(2022) Page Start: 276 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Review of companies and drug classes in the 2007–2011 antihypertensive patent literature. (March 2012) Authors: Carpino, Philip A; Flynn, Declan Journal: Pharmaceutical patent analyst Issue: Volume 1:Number 1(2013) Page Start: 45 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗